Search

everythinglearnresearchcommunity

for

Search:↓

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study aims to understand various diseases in older adults.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Minoxidil is mostly safe, but high doses can cause electrolyte imbalances and heart issues in dogs.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

The document concludes that more research is needed to fully understand the causes of PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.